Qube Research & Technologies (QRT)’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
OAM
USCWA
SWP
AA
CFD
Qube Research & Technologies (QRT)'s GNOM Position: Q1 2026 in Review
Qube Research & Technologies (QRT) reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 14% in Q1 2026, selling an estimated $1.99K and leaving 258 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3324.
Qube Research & Technologies (QRT) first reported a position in GNOM in Q4 2021 and has held it in 18 quarters since. The position peaked at $282K in Q2 2023. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.
- Qube Research & Technologies (QRT) held 258 shares of Global X Genomics & Biotechnology ETF worth $11.3K as of Q1 2026.
- Qube Research & Technologies (QRT) sold 43 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $1.99K.
- Global X Genomics & Biotechnology ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3324 holding.
- Qube Research & Technologies (QRT) first reported a position in Global X Genomics & Biotechnology ETF in Q4 2021 and has held it in 18 quarters since.
- Qube Research & Technologies (QRT)'s Global X Genomics & Biotechnology ETF position peaked at $282K in Q2 2023.
- 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.